Anterior Wall Myocardial Infarction

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death Abiomed recalls the instructions for use for Impella left sided blood pumps due to perforation risks. (Credit: Robina Weermeijer on Unsplash) Recalled Product US Available Product Names: Impella 2.5; Impella CP; Impella CP with SmartAssist; Impella 5.0; Impella 5.5 with SmartAssist ; Impella LD Distribution Dates: October 10, 2021 to October 10, 2023 Devices Recalled in the U.S.: 66,390 Date Initiated by Firm: December 27, 2023 Device Use Impella Left Sided Blood Pumps are used for short term support of the pumping chambers of the heart (ventricles) during high-risk catheter-based procedures called percutaneous coronary interventions (PCI). Impella Left Sided Blood Pumps also are used when there is ongoing cardiogenic shock that occurs less than 48 hours after a severe heart attack (acute myocardial infarction), open-heart surgery, or when the heart is not functioning well due to a condition called cardiomyopathy. Impella therapy aims to reduce the work of the heart’s ventricles and provide support for the circulatory system so the heart has time to recover. There are several types of Impella pumps that are used for different therapeutic reasons. Reason for Recall Abiomed is recalling its Impella Left Sided Blood Pumps because the pump catheter may perforate (cut) the wall of the left ventricle in the heart. During operations, the Impella device could cut through the wall of the left ventricle. The use of the affected Impella pumps may cause serious adverse health consequences, including left ventricle perforation or free wall rupture, hypertension, lack of blood flow, and death. There have been 129 reported serious injuries, including 49 reports of death. Who May be Affected People who are undergoing procedures with the Impella Left Sided Blood Pumps People who have anterior infarction (heart disease) Elderly people and women What to Do On December 27, 2023, Abiomed sent all affected customers an Urgent Medical Device Correction letter. The letter requested customers to adhere to new and revised warnings: Carefully position the pump catheter during operative procedures Use imaging when advancing or torquing the pump catheter Use special care when inserting the pump catheter in patients with certain high risk conditions or during active CPR Review the updated warnings in the device Instructions for Use Notify everyone at your facility who needs to be informed of this recall correction Notify any other facilities where the products have been forwarded of the updated Instructions for Use Source: Company Press Release

GALLOWAY, N.J.--( BUSINESS WIRE )--Atlantic Medical Imaging (AMI) , Inspira Health and Regional Diagnostic Imaging (RDI) are proud to announce a joint venture agreement involving several outpatient locations in South Jersey. Under the terms of the agreement, AMI, Inspira and RDI will partner at nine existing imaging centers, including three AMI locations (Upper Deerfield, Vineland and AMI Vascular Institute --Vineland). Also included are six Inspira locations (Sicklerville, Tomlin Station (Mullica Hill), Glassboro, Women’s Imaging Center Vineland, Delsea (Vineland), and Woolwich Township. All locations will be branded as AMI at Inspira Health. “This partnership will allow us to expand into Gloucester and Camden counties with a partner that has a long-standing history of serving these communities and will also allow us to provide an expanded suite of imaging and vascular services to patients,” according to Dr. David Levi, CEO of AMI. “AMI brings vast expertise in providing outpatient imaging services,” said Amy Mansue, president and CEO of Inspira Health. “By working together with them and our long-time radiology partner RDI, we will be able to increase access, schedule studies more quickly, expand services and enhance the patient experience for all of our patients.” The agreement is in effect as of June 12, 2023. Patients with appointments at any of the above locations will experience no changes in the date or time of their appointment. Patients with questions or who wish to make an appointment may call (856) 459-3855 or visit www.amiatinspira.com . About Atlantic Medical Imaging (AMI) Atlantic Medical Imaging (AMI) is a quality-driven medical imaging practice committed to clinical excellence by providing innovative service and compassionate care. With more than 63 board certified providers with extensive training in various medical subspecialties, 700 staff members and 17 office locations in Atlantic, Cape May, Cumberland, Ocean and Monmouth Counties, AMI is one of the largest and most comprehensive provider of imaging services in New Jersey. AMI started in 1964 as a one-man radiology practice. The goal was to serve the community by combining sensitive patient care with delivery of the most rapid, accurate diagnostic imaging services possible. The desire was to bring state-of-the-art diagnostic imaging technology and quality of care to the southern New Jersey region. The practice has grown as the area has grown yet the focus and commitment remains the same – to provide innovative service and compassionate care that exceeds expectations as the leading radiology practice in New Jersey. For more information about AMI visit www.aminj.com or call (609) 677-9729. About Inspira Health Inspira Health is a charitable nonprofit health care organization and a regional leader in physician training, with approximately 234 medical residents and fellows in 14 nationally accredited programs at its hospitals in Vineland, Mullica Hill and Elmer. The system traces its roots to 1899 and comprises three hospitals, two comprehensive cancer centers, eight multi-specialty health centers, and locations throughout South Jersey. These include urgent care; outpatient imaging and rehabilitation; sleep medicine labs; cardiac testing facilities; behavioral health, digestive health and wound care centers; home care and hospice; and more than 35 primary and specialty physician practices in Gloucester, Cumberland, Salem, Camden and Atlantic counties. Additionally, Inspira EMS services six South Jersey counties. Inspira’s 1,200-member medical staff and more than 7,000 employees provide an unwavering commitment to delivering a superior patient experience at every point of the journey. Technology and innovation investments provide a robust provider directory and a range of services, including online scheduling and virtual visits for both primary and specialty care providers. With a commitment to multi-channel digital access, Inspira is able to meet consumer demand for self-service and personalized care options. Salem Medical Center, an affiliate of Inspira Health, joined the Inspira Health Network in December 2022. The Salem Medical Center team includes approximately 350 employees and a 225-member medical staff. The hospital has served the community for more than 100 years. Accredited by DNV Healthcare and committed to the principles of high reliability, Inspira Health is focused on clinical excellence and patient safety. For more information about Inspira Health, visit http://www.InspiraHealthNetwork.org or call 1-800-INSPIRA About Regional Diagnostic Imaging Regional Diagnostic Imaging (RDI) has been the radiology provider for Inspira Health since 2006. Chaired by Dr. Lawrence Neustadter, the group has grown along with the hospital system and now comprises 30 radiologists, covering all subspecialties within the field. Under a new joint venture with AMI, the pooled resources and expertise of both groups will expand access and enhance the overall experience for the betterment of patients throughout the region.

TUESDAY, June 13, 2023 -- Patients with COVID-19 and acute myocardial infarction (AMI) experienced higher rates of mortality and complications than patients without COVID-19, with racial disparities identified, according to a study scheduled to be published in the September issue of Current Problems in Cardiology . Amer Muhyieddeen, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues assessed COVID-19's impact on racial disparities in AMI management and outcomes. Analysis included data from the first nine months of the COVID-19 pandemic, captured in the 2020 National Inpatient Sample data. The researchers found that patients with concurrent AMI and COVID-19 had higher in-hospital mortality (adjusted odds ratio [aOR], 3.19), increased mechanical ventilation (aOR, 1.90), and higher initiation of hemodialysis (aOR, 1.38) versus patients without COVID-19. Compared to White patients, Black and Asian/Pacific Islander patients had higher in-hospital mortality (aOR, 2.13 and 3.41, respectively). Black, Hispanic, and Asian/Pacific Islander patients had higher odds of starting hemodialysis (aOR, 5.48, 2.99, and 7.84, respectively). Furthermore, they were less likely to receive percutaneous coronary intervention for AMI (aOR, 0.71, 0.81, and 0.82, respectively). Coronary artery bypass grafting was less likely among Black patients (aOR, 0.55). "There are four main ways to address these disparities, which include improving access; providing culturally sensitive care; addressing social determinants of health; and policy changes," senior author Martha Gulati, M.D., also from Cedars-Sinai Medical Center, said in a statement. One author disclosed ties to Novartis and Esperion. Abstract/Full Text Posted June 2023 Further Support and Information on COVID-19 COVID-19: Prevention & Investigational Treatments COVID-19 Support Group Coronavirus Disease Guide